Calumet Q1 Earnings Call Highlights
Calumet (NASDAQ: CLMT) executives discussed their Q1 2026 earnings, highlighting strong margin conditions for both traditional and renewable fuels despite setbacks from a Shreveport facility downtime and planned work at Montana Renewables. The company achieved $50.1 million in adjusted EBITDA, slightly below the previous year, with significant contributions from its Montana Renewables segment and strategic price actions in Specialty Products and Solutions. Future plans include deleveraging and potentially monetizing Montana Renewables, especially after the MaxSAF project and improved RVO outlook.
Calumet (NASDAQ:CLMT) Issues Earnings Results
Calumet (NASDAQ:CLMT) reported Q1 2026 earnings per share of ($3.64), significantly missing analyst estimates of ($0.57), despite revenue of $1.03 billion slightly exceeding expectations and growing 3.6% year-over-year. The company cited an unexpected operational issue at its Shreveport plant, which caused substantial lost production and opportunity, but highlighted positive impacts from biofuel rules and improved fuels margins for its Montana Renewables segment. Following the earnings report, Calumet's stock declined by 7.3%, and insider activity showed a director selling shares in April.
Calumet Q1 Earnings Call Highlights
Calumet's Q1 2026 earnings call revealed a strategically pivotal period, despite first-quarter results not fully reflecting strong margin conditions due to downtime at its Shreveport facility and planned work at Montana Renewables. The company achieved $50.1 million in adjusted EBITDA, slightly below the previous year, influenced by an incident at Shreveport involving organic chlorides in the crude stream and temporary margin compression in Specialty Products and Solutions due to crude price spikes. Montana Renewables saw an increase in adjusted EBITDA, driven by the MaxSAF 150 expansion and an improved RVO outlook, with expectations of a significant shift towards sustainable aviation fuel production.
Calumet (NASDAQ:CLMT) Surprises With Q1 CY2026 Sales
Calumet (NASDAQ:CLMT) reported Q1 CY2026 sales of $1.03 billion, exceeding Wall Street expectations, though its GAAP loss of $3.64 per share and Adjusted EBITDA missed consensus estimates due to an unrealized loss for derivatives. The company highlighted a pivotal moment in its transformation and noted solid annualized revenue growth over the last five years, despite consistent negative free cash flow. The report suggests the latest quarter is one aspect of its business quality, which combined with valuation, can indicate if the stock is a buy.
(CLMT) Price Dynamics and Execution-Aware Positioning
This article analyzes Calumet Specialty Products Partners L.p. (NASDAQ: CLMT) using AI models, highlighting divergent sentiment across time horizons that suggests choppy conditions. It presents an exceptional short setup and outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored to different risk profiles, along with multi-timeframe signal analysis for support and resistance levels.
Calumet (CLMT) Projected to Post Earnings on Friday
Calumet (NASDAQ:CLMT) is projected to release its Q1 2026 earnings before market open on Friday, May 8th, with analysts expecting a loss of ($0.57) per share on $1.0011 billion in revenue. The company previously beat EPS estimates in the last quarter, reporting ($0.43) vs. consensus ($0.67). Institutional investors have adjusted their holdings, and analysts currently have a "Hold" consensus rating with a $30.50 price target on the stock.
Calumet, Inc. (NASDAQ:CLMT) Given Consensus Rating of "Hold" by Analysts
Calumet, Inc. (NASDAQ:CLMT) has received a consensus "Hold" rating from analysts, with an average one-year price target of $30.50. This mixed sentiment is despite the company beating its quarterly EPS estimates, reporting a loss of $0.43 against an estimated loss of $0.67, and showing a 9.4% year-over-year revenue increase to $1.04 billion. Recent insider activity includes a director selling over 3,300 shares, and institutional investors have made various adjustments to their holdings.
Why Calumet (CLMT) Shares Are Trading Lower Today
Shares of Calumet (NASDAQ:CLMT) fell 4.8% after Goldman Sachs downgraded the company's stock from Buy to Neutral, indicating a less optimistic short-term outlook. Despite the downgrade, Goldman Sachs increased their price target from $34 to $36. The stock has shown volatility, and while down today, it is up 59.8% year-to-date and has delivered significant returns over five years.
Calumet (NASDAQ:CLMT) Stock Price Down 6.2% - Should You Sell?
Calumet (NASDAQ:CLMT) stock dropped 6.2% to $30.75 on Friday after trading approximately 65% below its average daily volume, falling near its consensus target price. Analysts are divided on CLMT's outlook, with a consensus "Hold" rating and price targets ranging from $26 to $60. Despite exceeding Q4 EPS and revenue estimates, analysts project a negative EPS for the current year, while hedge funds have significantly increased their stakes in the company.
Calumet (NASDAQ:CLMT) Stock Passes Above 200 Day Moving Average - Time to Sell?
Calumet (NASDAQ:CLMT) stock has moved above its 200-day moving average, trading at $32.53, a notable technical breakout. Analyst opinions are mixed, with a consensus "Hold" rating and a target price of $30.17, although some analysts have significantly raised their price targets. Despite negative earnings, the company beat EPS estimates and saw a 9.4% increase in revenue.
Calumet to produce renewable diesel at Montana refinery
Calumet Specialty Products Partners announced in February 2021 its intention to produce renewable diesel at its Great Falls, Montana refinery. This move signifies the company's entry into the renewable fuels market and aligns with growing industry trends towards sustainable energy production. The original article is from February 2021, and this re-published piece from 2026 refers to that older announcement.
Calumet, Inc. (NASDAQ:CLMT) Receives Consensus Rating of "Hold" from Brokerages
Eight brokerage firms have issued a "Hold" consensus rating for Calumet, Inc. (NASDAQ:CLMT), with an average one-year price target of $30.17. The company recently reported Q4 EPS of -$0.43, outperforming estimates, and revenue of $1.04 billion, a 9.4% year-over-year increase. Despite some insider selling, institutional ownership in Calumet stands at 34.41%, with several funds increasing their stakes.
Calumet (NASDAQ:CLMT) Director Daniel Sajkowski Sells 3,310 Shares
Calumet Director Daniel Sajkowski sold 3,310 shares of the company's stock on April 1st for a total of $114,062.60, reducing his stake by 3.88%. This transaction comes as Calumet has shown strong Q4 earnings, beating analyst expectations, and has seen its stock price rally towards a 52-week high with increased analyst attention, despite facing some near-term operational risks from unplanned maintenance.
Calumet director Sajkowski sells $114k in shares By Investing.com
Calumet director Daniel J. Sajkowski sold 3,310 shares of common stock for a total of $114,062 on April 1, 2026. The transaction was executed under a Rule 10b5-1 trading plan. This sale occurred while CLMT stock is trading near its 52-week high, having delivered significant returns over the past year.
HC Wainwright Issues Positive Outlook for Calumet Earnings
HC Wainwright has issued a positive outlook for Calumet (NASDAQ:CLMT), increasing its 2026 quarterly EPS estimates and forecasting a return to profitability with FY2027 EPS of $1.07. The firm reiterated a "Buy" rating and a $60 price target, despite the street's consensus still predicting multi-quarter losses. The stock saw a 12% jump on the news, reflecting investor reaction to the upgraded forecasts.
H.C. Wainwright raises Calumet stock price target to $60 from $33 By Investing.com
H.C. Wainwright significantly increased its price target for Calumet Specialty Products Partners (CLMT) to $60 from $33, while maintaining a Buy rating. This adjustment reflects improved adjusted EBITDA projections for 2026 and 2027, driven by expectations of better pricing and demand for renewable fuels. Despite this bullish outlook, InvestingPro analysis suggests the stock might be overvalued, though the company has also been active in debt reduction and pre-selling sustainable aviation fuel (SAF).
Calumet (NASDAQ:CLMT) Given New $60.00 Price Target at HC Wainwright
HC Wainwright has raised its price target for Calumet (NASDAQ:CLMT) to $60.00 from $33.00, maintaining a "buy" rating and suggesting an 87% upside. This new target contributes to a mixed analyst consensus of "Hold" with an average target of $30.17. The oil and gas company recently surpassed EPS estimates and saw a 9.4% increase in revenue year-over-year.
H.C. Wainwright raises Calumet stock price target to $60 from $33
H.C. Wainwright significantly increased its price target for Calumet Specialty Products Partners (NASDAQ: CLMT) to $60 from $33, while maintaining a Buy rating. This adjustment is based on raised adjusted EBITDA projections for 2026 and 2027, driven by expected improvements in renewable fuel pricing and demand. Despite the bullish outlook, InvestingPro analysis suggests the stock might be overvalued at its current trading levels.
Adams Asset Advisors LLC Has $102.46 Million Stock Position in Calumet, Inc. $CLMT
Adams Asset Advisors LLC has a $102.46 million stock position in Calumet, Inc. (NASDAQ:CLMT), representing its second-largest holding and 13.5% of its portfolio, despite trimming its stake by 4.6% in Q4. Calumet reported a Q4 EPS of ($0.43), beating estimates, with revenue up 9.4% year-over-year. The stock currently trades around $32.06, and analysts maintain a mixed outlook with an average "Hold" rating, though Goldman Sachs raised its target to $34 with a "buy" rating.
$150M notes deal lets Calumet cut revolver borrowings now
Calumet (NASDAQ: CLMT) completed a private placement of $150 million aggregate principal amount of 9.75% Senior Notes due 2031, issued at 105% of par, generating net proceeds of approximately $154.9 million. The company intends to use these proceeds to immediately repay outstanding borrowings under its revolving credit facility. This transaction is part of Calumet's strategy to enhance liquidity and may also be used to reduce 2028 notes when the call premium declines in July, building on a previous $405 million notes issuance in January 2026.
(CLMT) Movement as an Input in Quant Signal Sets
This article provides an in-depth quantitative analysis of Calumet Specialty Products Partners L.p. (NASDAQ: CLMT), highlighting strong near-term sentiment with a long-term positive bias. It presents three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for various risk profiles, along with multi-timeframe signal analysis indicating support and resistance levels. The report emphasizes the absence of clear price positioning signals and elevated downside risk due to a lack of additional long-term support signals.
X3Q Stock Price and Chart — DUS:X3Q
This page provides detailed financial information for Calumet, Inc. (DUS:X3Q) including its stock price chart, key statistics, upcoming earnings dates, and analyst ratings. It highlights the company's segments in specialty products and renewables, its revenue, net income, and market capitalization, along with various trading ideas and ETFs holding the stock.
Calumet plans $150M 9.75% debt sale to repay credit line
Calumet announced a private placement of an additional $150 million of 9.75% Senior Notes due 2031, which will form a single series with existing notes, bringing the total to $555 million. The net proceeds are intended to repay outstanding borrowings under the company's revolving credit facility. This move continues Calumet's strategy of using private placements to refinance and extend debt maturities, aiming to reduce short-term secured borrowings despite increasing fixed interest obligations.
Calumet stock hits 52-week high at $31.41 amid strong performance
Calumet Specialty Products Partners, L.P. (CLMT) stock reached a new 52-week high of $31.41, reflecting a 145% increase over the past year. Despite this strong market performance, an InvestingPro analysis suggests the stock is currently overvalued and the company remains unprofitable with an EPS of -$0.39. Recent Q4 2025 earnings missed EPS forecasts but exceeded revenue expectations, and the company completed a $150 million private placement of senior notes.
Calumet stock hits 52-week high at $31.41 amid strong performance
Calumet Specialty Products Partners, L.P. (CLMT) stock reached a new 52-week high of $31.41, reflecting a 145% increase over the past year. Despite this strong market performance and investor confidence, InvestingPro analysis suggests the stock is currently overvalued and the company remains unprofitable with an EPS of -$0.39. Recent financial news for Calumet includes missing Q4 2025 EPS estimates while slightly exceeding revenue expectations, completing a $150 million private placement of Senior Notes, and announcing a board member's retirement.
Calumet (CLMT) Board Member Jennifer Straumins to Retire by 2026
Calumet Specialty Products Partners, L.P. (CLMT) announced that Board member Jennifer Straumins will retire at the 2026 Annual Meeting of Stockholders, having served on the Board since July 2024 and previously with Calumet GP, LLC. The company, which operates in the Basic Materials sector producing specialty and fuel-related products, faces significant financial challenges including negative revenue growth, a negative net margin, and a distressed Altman Z-Score, indicating potential bankruptcy risk. Despite its market presence, high leverage and declining revenue suggest a need for strategic improvements to enhance its financial health and market position.
Calumet Specialty Products Partners Announces Board Member Will Not Seek Re-Election in 2026
Calumet Specialty Products Partners, L.P. announced that one of its board members will not seek re-election at the end of their current term, a decision disclosed on March 25, 2026. The company did not provide reasons for the departure or details about potential replacements. This development occurs as Calumet continues its operations in specialty products and refining, with no further updates on board composition or governance impacts.
Calumet Specialty Prods stock faces headwinds amid fuel segment challenges and strategic shifts
Calumet Specialty Products Partners is struggling with declining fuel margins and production issues, forcing a strategic shift towards sustainable aviation fuel (SAF) and specialty lubricants. While the fuel segment faces headwinds with production halts and compressed crack spreads, the company's specialty products division shows stability. Investors are watching its sustainability efforts and debt management closely, as high leverage and suspended distributions present challenges despite potential long-term benefits from decarbonization trends.
Calumet Specialty Prods stock faces headwinds amid fuel segment challenges and strategic shifts
Calumet Specialty Products is facing challenges in its fuel segment due to declining margins and production issues, prompting a strategic shift towards specialty products and sustainable aviation fuel (SAF). The company's Great Falls facility is now producing SAF, and its specialty products division continues to provide stability. Investors are closely watching Calumet's debt management and its transition efforts amidst market volatility.
Calumet raises $150M through senior notes offering By Investing.com
Calumet, Inc. has successfully completed a private placement, raising $150 million through 9.75% Senior Notes due 2031, with net proceeds of approximately $154.9 million after expenses. This offering follows an earlier issuance and aims to repay outstanding borrowings under its revolving credit facility and reduce 2028 notes. Despite a surging stock price, Calumet remains unprofitable, and its stock is considered overvalued according to InvestingPro analysis, while the company also reported an EPS miss in its latest earnings.
Calumet Completes Offering of $150 Million of Additional 9.75% Senior Notes due 2031
Calumet, Inc. has announced the completion of a private placement offering of an additional $150 million in 9.75% Senior Notes due 2031. The net proceeds of approximately $154.9 million will be used to immediately repay outstanding borrowings under its revolving credit facility. This issuance builds on an earlier offering of $405 million in similar notes and is expected to provide additional liquidity for potentially reducing 2028 notes when their call premium steps down in July.
Liquidity Mapping Around (CLMT) Price Events
The article provides an AI-driven analysis of Calumet Specialty Products Partners L.p. (NASDAQ: CLMT), identifying weak near-term sentiment but long-term strength. It outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis for support and resistance levels. The analysis highlights an exceptional risk-reward short setup and offers real-time signals for institutional trading strategies.
Calumet (NASDAQ: CLMT) adds $150M 9.75% notes to 2031 debt stack
Calumet, Inc. announced the completion of a private placement for an additional $150 million of 9.75% Senior Notes due 2031, effectively expanding its existing debt series to $555 million. The company will use the approximately $154.9 million in net proceeds to pay down its revolving credit facility, converting short-term debt into longer-dated, fixed-rate notes. This strategic financial move aims to stabilize liquidity, reduce refinancing risk, and provide flexibility for Calumet's operations, including its Montana Renewables expansion.
Calumet, Inc. (NASDAQ:CLMT) Sees Large Decrease in Short Interest
Calumet, Inc. (NASDAQ:CLMT) experienced a significant 21.9% decrease in short interest during February, with 5,441,750 shares shorted by February 27th, representing about 6.5% of the stock. Analysts currently hold a "Hold" consensus with an average price target of $25.67, despite mixed ratings. The company recently surpassed Q4 EPS estimates, reporting -$0.43 against an expected -$0.67, with revenue of $1.04 billion.
Calumet Prices New Senior Notes to Refinance Credit Facility
Calumet Specialty Products (CLMT) has priced a $150 million private placement of 9.75% Senior Notes due 2031, with proceeds aimed at refinancing its revolving credit facility. This move is expected to simplify its capital structure and strengthen relationships with lenders. Despite the financial restructuring, TipRanks' AI Analyst, Spark, rates CLMT as Neutral due to weak financial fundamentals, though technicals show strong trend support.
Calumet Announces $150M Private Placement of 9.75% Senior Notes
Calumet, Inc. (NASDAQ: CLMT) announced a private placement offering of $150 million in 9.75% Senior Notes due 2031, which will form a single series with its existing notes. The company plans to use the net proceeds to repay outstanding borrowings under its revolving credit facility, enhancing its financial flexibility. This move is crucial for the specialty chemicals and renewable fuels manufacturer to fund operations and growth initiatives.
Calumet, Inc. (NASDAQ:CLMT) Receives Average Recommendation of "Hold" from Brokerages
Calumet, Inc. (NASDAQ:CLMT) has received an average "Hold" rating from eight brokerages, with a consensus 12-month price target of $24.00. The company recently reported quarterly earnings of ($0.43) per share, surpassing analyst expectations, and revenue increased by 9.4% year-over-year. Institutional investors hold approximately 34.41% of the stock.
Calumet plans $150M bond offering to refinance credit facility
Calumet, Inc. (NASDAQ:CLMT) announced its subsidiaries intend to offer $150 million in 9.75% Senior Notes due 2031 through a private placement to refinance its revolving credit facility. This new offering follows a previous issuance of $405 million of the same notes and comes as the company carries significant debt relative to its market capitalization. Despite a recent earnings miss, the stock has seen a substantial surge over the past year.
FY2029 EPS Estimates for Calumet Lowered by HC Wainwright
HC Wainwright has lowered its FY2029 earnings per share estimate for Calumet (NASDAQ:CLMT) to $2.48, down from $2.49, while maintaining a "Buy" rating and a $33.00 price target. The oil and gas company's stock currently has a consensus "Hold" rating and a target price of $22.83 from eight analysts. Calumet recently beat quarterly earnings estimates but showed a revenue decline compared to analyst expectations.
Calumet, Inc. (NASDAQ:CLMT) Q4 2025 Earnings Call Transcript
Calumet, Inc. (NASDAQ: CLMT) held its Q4 and full-year 2025 earnings call, discussing its strategic achievements, financial performance, and future outlook. The company highlighted significant deleveraging, increased adjusted EBITDA, and operational improvements across its Specialty Products and Solutions and Montana Renewables segments. Key points included successfully closing the DOE loan for Montana Renewables, launching the MaxSAF 150 expansion, and continued strong performance in its Specialties business, despite missing Q4 2025 EPS expectations.
Insider Selling: Calumet (NASDAQ:CLMT) Director Sells 20,000 Shares of Stock
Calumet (NASDAQ:CLMT) Director Daniel Sajkowski sold 20,000 shares of the company's stock for $251,000 on April 1st, reducing his stake by 14.09%. This transaction occurred as CLMT shares traded up 2.1% to $30.22, nearing its 52-week high. Analysts hold a mixed view on the stock, with a "Hold" consensus rating and an average price target of $22.83, although Goldman Sachs recently upgraded its target to $24 with a "Buy" rating.
Calumet (NASDAQ: CLMT) director sells 82,000 shares under 10b5-1 plan
Calumet, Inc. director Daniel J. Sajkowski sold a total of 82,000 shares of common stock in five transactions between March 3 and July 1, 2025, under a pre-arranged Rule 10b5-1 trading plan. The sales occurred at weighted average prices ranging from $10.66 to $15.77 per share. Following these transactions, Sajkowski's direct holdings in Calumet, Inc. common stock stand at 82,237 shares.
Calumet stock hits 52-week high at 29.93 USD
Calumet Specialty Products Partners (CLMT) stock reached a 52-week high of $29.93, trading just 1% below this peak with a market capitalization of $2.58 billion. The stock has surged 91.5% in the last 12 months, reflecting strong market performance, although InvestingPro data suggests it might be overvalued. The company recently completed a $405 million senior notes offering, extended its revolving credit facility, and its subsidiary, Montana Renewables, secured a three-year agreement to supply Sustainable Aviation Fuel.
Calumet (NASDAQ:CLMT) Director Sells $268,000.00 in Stock
Calumet (NASDAQ:CLMT) Director Daniel Sajkowski sold 20,000 shares of the company's stock on June 2nd, totaling $268,000. This sale reduced his stake by 19.62%. The company's stock recently traded at $30.22, nearing its 12-month high, while analysts maintain a "Hold" consensus rating with an average price target of $22.83.
Insider Selling: Calumet (NASDAQ:CLMT) Director Sells $274,600.00 in Stock
Calumet (NASDAQ:CLMT) Director Daniel Sajkowski sold 20,000 shares of the company's stock on March 3rd for $274,600, reducing his stake by 12.35%. This transaction comes as Calumet is trading near its 52-week high, with analysts holding a consensus "Hold" rating and an average price target below the current trading price. Institutional investors increased their holdings in Q4, and now own approximately 34.41% of the shares.
Understanding Momentum Shifts in (CLMT)
This article analyzes Calumet Specialty Products Partners L.p. (NASDAQ: CLMT) using AI models to identify momentum shifts and provide trading strategies. It highlights strong sentiment across all horizons, no clear price positioning, and elevated downside risk due to a lack of additional long-term support signals. The analysis includes position trading, momentum breakout, and risk hedging strategies tailored to different risk profiles.
70M gallons of cleaner aviation fuel to cut 600,000 MT CO2
Calumet (NASDAQ: CLMT) subsidiary Montana Renewables and World Energy have partnered to deliver over 70 million gallons of Sustainable Aviation Fuel (SAF) across three years, aiming to reduce CO2 emissions by up to 600,000 metric tons. This collaboration supports U.S. agriculture and energy independence, with Montana Renewables' MaxSAF™ 150 expansion progressing to meet demand. The long-term contract with World Energy validates MRL's capital investments and accelerates the supply of SAF.
Calumet stock (CLMT) slips in premarket after Friday surge, with Feb 27 earnings next
Calumet (CLMT) stock saw a 2.1% premarket dip after a 10.1% surge on February 13th, ahead of its Q4 and full-year 2025 earnings report on February 27th. Investors are keen on updates regarding cash generation, the balance between specialty products and renewables, and any changes in the company's financial outlook, especially after recent debt refinancings. The upcoming earnings call will be crucial for guidance, margin discussions, and renewable energy plans.
UBS Upgrades Calumet Inc(CLMT.US) to Hold Rating, Raises Target Price to $26
UBS analyst Manav Gupta has upgraded Calumet Inc (CLMT.US) to a hold rating from a previous rating, and significantly increased its target price from $15 to $26. Gupta has a strong track record, with a 68.3% success rate and an average return of 13.6% over the last year, according to TipRanks data. This information is provided for educational purposes and should not be considered investment advice.
Calumet, Inc. (NASDAQ:CLMT) Receives Consensus Rating of "Hold" from Analysts
Calumet, Inc. (NASDAQ:CLMT) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $22.83. Institutional investors hold approximately 34.41% of the stock, with significant recent buys, and shares opened at $28.61, near a 1-year high. The company, an independent provider of high-value petroleum and renewable feedstock solutions, has a market capitalization of $2.48 billion.
